Coulston James has filed 4 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 600000 shares of PROKIDNEY CORP. ($PROK) on March 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 1, 2026 | PROKIDNEY CORP. | $PROK | Coulston James | Chief Financial Officer | A | Employee stock option (right to buy) | 600000 | $0.00 | 600,000.0000 | 159,288,931 | 9999.99% | 0.38% |
| March 1, 2025 | PROKIDNEY CORP. | $PROK | Coulston James | Chief Financial Officer | A | Employee stock option (right to buy) | 650000 | $0.00 | 650,000.0000 | 163,693,707 | 9999.99% | 0.40% |
| March 1, 2024 | PROKIDNEY CORP. | $PROK | Coulston James | Chief Financial Officer | A | Employee stock option (right to buy) | 275000 | $0.00 | 275,000.0000 | 168,297,916 | 9999.99% | 0.16% |
| Jan. 16, 2023 | PROKIDNEY CORP. | $PROK | Coulston James | Chief Financial Officer | A | Employee stock option, right to buy | 290000 | $0.00 | 290,000.0000 | 171,578,320 | 9999.99% | 0.17% |